Nanocarriers of shRNA-Runx2 directed to collagen IV as a nanotherapeutic system to target calcific aortic valve disease-Reference-Cited by-同舟云学术

Nanocarriers of shRNA-Runx2 directed to collagen IV as a nanotherapeutic system to target calcific aortic valve disease

Published:2023-06 Issue: Volume:20 Page:100620
ISSN:2590-0064
Container-title:Materials Today Bio
language:en
Short-container-title:Materials Today Bio

Author:

Voicu Geanina,Mocanu Cristina Ana,Safciuc Florentina,Anghelache Maria,Deleanu Mariana,Cecoltan Sergiu,Pinteala Mariana,Uritu Cristina Mariana^ORCID,Droc Ionel,Simionescu Maya,Manduteanu Ileana^ORCID,Calin Manuela^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biomedical Engineering,Biomaterials,Bioengineering,Biotechnology

Reference51 articles.

1. Innate and adaptive immunity in calcific aortic valve disease;Mathieu;J Immunol Res,2015

2. The role of Lrp5/6 in cardiac valve disease: experimental hypercholesterolemia in the ApoE−/−/Lrp5−/− mice;Rajamannan;J. Cell. Biochem.,2011

3. Does diabetes accelerate the progression of aortic stenosis through enhanced inflammatory response within aortic valves?;Natorska;Inflammation,2012

4. Aortic stenosis and diabetes mellitus: an ominous combination;Banovic;Diabetes Vasc. Dis. Res.,2019

5. Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases;Larsson;Int. J. Cardiol.,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Models for calcific aortic valve disease in vivo and in vitro;Cell Regeneration;2024-03-01

2. Advances in Atherosclerosis Theranostics Harnessing Iron Oxide‐Based Nanoparticles;Advanced Science;2024-02-17

3. Enhancing aortic valve drug delivery with PAR2-targeting magnetic nano-cargoes for calcification alleviation;Nature Communications;2024-01-16